Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Mar 03 2015

Drug Use in High-Deductible Health Plans

By Kevin Roche Commentary One Comment
A paper at the National Bureau of Economic Research explores how patients in high-deductible health plans changed behavior in regard to drug use.
Read More
Mar 02 2015

IMS on Health Care Trends

By Kevin Roche Commentary No Comments
A report from the IMS Institute for Healthcare Informatics gives the firm's perspective on trends affecting the pharmaceutical industry.
Read More
Feb 27 2015

Innovation in Medical Products

By Kevin Roche Commentary No Comments
The current issue of Health Affairs is focused on innovation in medical products, suggesting that it may be hindered by less funding and regulatory and reimbursement hurdles.
Read More
Feb 26 2015

Wellness Program Survey

By Kevin Roche Commentary No Comments
The International Foundation of Employee Benefit Plans conducted a survey last year of over 450 employers in the United States and Canada to learn details about their wellness program activities.
Read More
Feb 25 2015

Hospital Readmissions and Hospital Location

By Kevin Roche Commentary No Comments
Yet another study, this one carried by Health Services Research, suggests that current methods for encouraging fewer inappropriate hospital readmissions are inadequate to avoid wrongly punishing hospitals for events beyond…
Read More
Feb 24 2015

2016 Medicare Advantage Call Letter

By Kevin Roche Commentary No Comments
The always eagerly-awaited Medicare Advantage Call Letter, this one for 2016, is now available, promising a meager premium increase for plans.
Read More
Feb 23 2015

Health Care Benefit Trends Report

By Kevin Roche Commentary No Comments
A survey sponsored by Evolution1's Healthcare Trends Institute focuses on employer health benefit trends.
Read More
Feb 20 2015

Generic Drug Price Increases

By Kevin Roche Commentary One Comment
A paper from Elsevier explores reasons for the recent uptick in generic drug prices.
Read More
Feb 19 2015

The Cost of Hypertension Guideline Compliance

By Kevin Roche Commentary No Comments
Research in the New England Journal of Medicine looks at whether the most recent guidelines in blood pressure control would lead to cost savings.
Read More
Feb 18 2015

Reasons for Readmissions after Surgery

By Kevin Roche Commentary No Comments
CMS is extending hospital readmission penalties to surgeries. An article in the Journal of the American Medical Association examines reasons for such readmissions, which is kind of a core predicate…
Read More
  • « Previous
  • 1
  • …
  • 467
  • 468
  • 469
  • 470
  • 471
  • …
  • 623
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

Angle Health, a vendor of a supposedly artificial intelligence powered health benefits platform for employers raised $134 million in new capital.  All you have to do is mention AI and...
December 4, 2025
Reema Health, which calls itself a complex care management company, reamed investors for $19 million in capital, to be used for the usual “to support growth”.  The firm works with...
December 2, 2025
Press Ganey, which provides market research for health plans and providers , is being purchased by health care survey firm Qualtrics for $6.75 billion.  Both companies claim this is all...
October 6, 2025
Another weirdly named company, Thyme Care, spices things up by raising a fresh $97 million in capital to support its cancer care managment business.
September 25, 2025

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1843) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Health Affairs
  • Congressional Budget Office

RSS Feed

RSS feed

© 2025 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts